Skip to content

REIN THERAPEUTICS, INC.

RNTX

CIK 0001420565

← back to feed
Revenue (TTM)
$0
Q1 May 2026
Net Income (TTM)
−$23.74M
+20.7% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.93
+44.2% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$19.79M
Q1 May 2026
Cash
$4.45M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
85.54M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings